CompletedNCT00643123
Allopurinol or placebo added to care for resistant mania in bipolarity
About this title
Read the official source — NCT00643123Medication studyAges 18–70United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 70 years.
- Listed locations
- Los AngelesSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateSeptember 2007
- Recruitment status
- Completed
- Enrollment listed in the registry
- 40
- Sponsor
- Cedars-Sinai Medical Center
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug, OTHER
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT00643123
- Official title
Show the full official title
A Double-Blind, Placebo Controlled Augmentation Study With Allopurinol for Treatment Resistant Mania
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedLos Angeles
Questions about this study
Who is behind this study?
The study sponsor is Cedars-Sinai Medical Center, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Allopurinol.
Who was this study for?
Listed age limits: 18 years to 70 years.
